ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 138 filers reported holding ARRAY BIOPHARMA INC in Q1 2015. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $186,510,000 | +144.7% | 4,025,690 | +28.8% | 0.05% | +134.8% |
| Q1 2019 | $76,226,000 | +171.0% | 3,126,574 | +58.4% | 0.02% | +155.6% |
| Q4 2018 | $28,130,000 | +217.2% | 1,974,064 | +238.4% | 0.01% | +350.0% |
| Q3 2018 | $8,868,000 | -46.7% | 583,397 | -41.2% | 0.00% | -60.0% |
| Q2 2018 | $16,652,000 | -46.3% | 992,392 | -47.7% | 0.01% | -37.5% |
| Q1 2018 | $30,984,000 | +162.6% | 1,898,518 | +105.9% | 0.01% | +166.7% |
| Q4 2017 | $11,801,000 | -44.8% | 921,953 | -47.0% | 0.00% | -40.0% |
| Q3 2017 | $21,397,000 | +76.7% | 1,739,631 | +20.2% | 0.01% | +66.7% |
| Q2 2017 | $12,109,000 | +24.7% | 1,446,775 | +33.2% | 0.00% | 0.0% |
| Q1 2017 | $9,711,000 | +153.9% | 1,086,240 | +149.6% | 0.00% | +200.0% |
| Q4 2016 | $3,825,000 | +66.7% | 435,183 | +28.0% | 0.00% | 0.0% |
| Q3 2016 | $2,295,000 | +151.4% | 340,072 | +32.5% | 0.00% | – |
| Q2 2016 | $913,000 | -45.6% | 256,666 | -54.9% | 0.00% | -100.0% |
| Q1 2016 | $1,679,000 | -60.0% | 568,890 | -42.9% | 0.00% | 0.0% |
| Q4 2015 | $4,200,000 | -42.8% | 995,470 | -38.2% | 0.00% | -66.7% |
| Q3 2015 | $7,343,000 | -44.2% | 1,610,214 | -11.8% | 0.00% | -25.0% |
| Q2 2015 | $13,171,000 | -10.8% | 1,826,673 | -8.8% | 0.00% | 0.0% |
| Q1 2015 | $14,763,000 | +723.4% | 2,003,159 | +428.2% | 0.00% | – |
| Q4 2014 | $1,793,000 | +7.5% | 379,229 | -18.9% | 0.00% | – |
| Q3 2014 | $1,668,000 | -17.6% | 467,559 | +5.3% | 0.00% | – |
| Q2 2014 | $2,025,000 | +25.8% | 443,885 | +29.6% | 0.00% | -100.0% |
| Q1 2014 | $1,610,000 | +925.5% | 342,498 | +994.1% | 0.00% | – |
| Q4 2013 | $157,000 | -93.5% | 31,305 | -91.9% | 0.00% | -100.0% |
| Q3 2013 | $2,406,000 | -28.4% | 386,871 | -47.8% | 0.00% | 0.0% |
| Q2 2013 | $3,362,000 | +22.3% | 740,542 | +0.2% | 0.00% | 0.0% |
| Q4 2012 | $2,748,000 | -6.2% | 738,698 | +47.4% | 0.00% | 0.0% |
| Q3 2012 | $2,929,000 | +26.7% | 501,089 | -24.8% | 0.00% | 0.0% |
| Q2 2012 | $2,311,000 | +2258.2% | 665,929 | +2214.3% | 0.00% | – |
| Q1 2012 | $98,000 | – | 28,774 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 9,169,276 | $66,110,000 | 11.67% |
| Redmile Group, LLC | 13,623,620 | $98,226,000 | 8.05% |
| First Light Asset Management, LLC | 849,374 | $6,124,000 | 2.88% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,529,361 | $68,707,000 | 2.29% |
| Opus Point Partners Management, LLC | 320,000 | $2,307,000 | 1.83% |
| KOPP INVESTMENT ADVISORS LLC | 383,022 | $2,762,000 | 1.23% |
| Artal Group S.A. | 3,710,000 | $26,749,000 | 1.15% |
| EcoR1 Capital, LLC | 400,000 | $2,884,000 | 0.96% |
| Cormorant Asset Management, LP | 850,000 | $6,129,000 | 0.82% |
| SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $5,768,000 | 0.56% |